BACKGROUND: Cerebrovascular time constant (τ) estimates how fast cerebral blood arrives in cerebral arterial bed after each heart stroke. We investigate the pattern of changes in τ following subarachnoid hemorrhage (SAH), with specific emphasis on the temporal profile of changes in relation to the development of cerebral vasospasm. METHODS: Simultaneous recordings of arterial blood pressure (ABP) and transcranial Doppler (TCD) blood flow velocity (CBFV) in MCA were performed daily in patients after SAH. In 22 patients (10 males and 12 females; median age: 48 years, range: 34-84 years) recordings done before spasm were compared to those done during spasm. Vasospasm was confirmed with TCD (mean CBFV in MCA > 120 cm/s and Lindegaard ratio > 3). τ was estimated as a product of compliance of cerebral arteries (C (a)) and cerebrovascular resistance (CVR). C (a) and CVR were estimated using mathematical transformations of ABP and CBFV waveforms. RESULTS: Vasospasm caused shortening of τ on both the spastic (before: 0.20 ± 0.05 s vs. spasm: 0.14 ± 0.04 s, P < 0.0008) and contralateral side (before: 0.22 ± 0.05 s vs. spasm: 0.16 ± 0.04 s, P < 0.0008). Before TCD signs of vasospasm were detected, τ demonstrated asymmetry with lower values on ipsilateral side to aneurysm, in comparison to contralateral side (P < 0.009), CONCLUSIONS: Cerebral vasospasm causes shortening of τ. Shorter τ at the side of aneurysm can be observed before formal TCD signs of vasospasm are observed, therefore, potentially reducing time to escalation of treatment.
BACKGROUND: Cerebrovascular time constant (τ) estimates how fast cerebral blood arrives in cerebral arterial bed after each heart stroke. We investigate the pattern of changes in τ following subarachnoid hemorrhage (SAH), with specific emphasis on the temporal profile of changes in relation to the development of cerebral vasospasm. METHODS: Simultaneous recordings of arterial blood pressure (ABP) and transcranial Doppler (TCD) blood flow velocity (CBFV) in MCA were performed daily in patients after SAH. In 22 patients (10 males and 12 females; median age: 48 years, range: 34-84 years) recordings done before spasm were compared to those done during spasm. Vasospasm was confirmed with TCD (mean CBFV in MCA > 120 cm/s and Lindegaard ratio > 3). τ was estimated as a product of compliance of cerebral arteries (C (a)) and cerebrovascular resistance (CVR). C (a) and CVR were estimated using mathematical transformations of ABP and CBFV waveforms. RESULTS:Vasospasm caused shortening of τ on both the spastic (before: 0.20 ± 0.05 s vs. spasm: 0.14 ± 0.04 s, P < 0.0008) and contralateral side (before: 0.22 ± 0.05 s vs. spasm: 0.16 ± 0.04 s, P < 0.0008). Before TCD signs of vasospasm were detected, τ demonstrated asymmetry with lower values on ipsilateral side to aneurysm, in comparison to contralateral side (P < 0.009), CONCLUSIONS:Cerebral vasospasm causes shortening of τ. Shorter τ at the side of aneurysm can be observed before formal TCD signs of vasospasm are observed, therefore, potentially reducing time to escalation of treatment.
Authors: Dong-Joo Kim; Magdalena Kasprowicz; Emmanuel Carrera; Gianluca Castellani; Christian Zweifel; Andrea Lavinio; Peter Smielewski; Michael P F Sutcliffe; John D Pickard; Marek Czosnyka Journal: Physiol Meas Date: 2009-06-05 Impact factor: 2.833
Authors: Joshua B Bederson; E Sander Connolly; H Hunt Batjer; Ralph G Dacey; Jacques E Dion; Michael N Diringer; John E Duldner; Robert E Harbaugh; Aman B Patel; Robert H Rosenwasser Journal: Stroke Date: 2009-01-22 Impact factor: 7.914
Authors: Wesley B Baker; Ashwin B Parthasarathy; Kimberly P Gannon; Venkaiah C Kavuri; David R Busch; Kenneth Abramson; Lian He; Rickson C Mesquita; Michael T Mullen; John A Detre; Joel H Greenberg; Daniel J Licht; Ramani Balu; W Andrew Kofke; Arjun G Yodh Journal: J Cereb Blood Flow Metab Date: 2017-05-25 Impact factor: 6.200
Authors: Georgios V Varsos; Nicolás de Riva; Peter Smielewski; John D Pickard; Ken M Brady; Matthias Reinhard; Alberto Avolio; Marek Czosnyka Journal: Neurocrit Care Date: 2013-06 Impact factor: 3.210
Authors: C Puppo; J Camacho; G V Varsos; B Yelicich; H Gómez; L Moraes; A Biestro; M Czosnyka Journal: Neurocrit Care Date: 2016-12 Impact factor: 3.210
Authors: Christopher J Rhee; Charles D Fraser; Kathleen Kibler; Ronald B Easley; Dean B Andropoulos; Marek Czosnyka; Georgios V Varsos; Peter Smielewski; Craig G Rusin; Ken M Brady; Jeffrey R Kaiser Journal: Pediatr Res Date: 2015-03-31 Impact factor: 3.756
Authors: Georgios V Varsos; Karol P Budohoski; Angelos G Kolias; Xiuyun Liu; Peter Smielewski; Vassilis G Varsos; Peter J Hutchinson; John D Pickard; Marek Czosnyka Journal: Neurocrit Care Date: 2014-10 Impact factor: 3.210
Authors: Georgios V Varsos; Hugh Richards; Magdalena Kasprowicz; Karol P Budohoski; Ken M Brady; Matthias Reinhard; Alberto Avolio; Peter Smielewski; John D Pickard; Marek Czosnyka Journal: J Cereb Blood Flow Metab Date: 2012-11-14 Impact factor: 6.200
Authors: Georgios V Varsos; Hugh K Richards; Magdalena Kasprowicz; Matthias Reinhard; Peter Smielewski; Ken M Brady; John D Pickard; Marek Czosnyka Journal: Neurocrit Care Date: 2014-02 Impact factor: 3.210